New research now suggests that cannabis may have positive effects in the fight against chronic traumatic encephalopathy (CTE), a degenerative brain disease brought on by repeated head trauma over the years.
To be sure, the National Football League is now very much aware of CTE diagnoses among its players. And despite its unfortunate legacy of sweeping the problem under the rug, a now proactive NFL is trying to combat it.
This could end up being a massive catalyst for marijuana stocks...
If you gave Money Morning Technical Trading Specialist D.R. Barton, Jr., 10 minutes, he could make you a millionaire.
He doesn't care if you start with $10 or $10,000.
If your goal is to amass $1 million or more, that goal is within your reach...
The life-changing potential in this revolutionary medical procedure is no secret…
In fact, you may have already heard about its potential to not just cure diseases, but to erase them entirely.
You've probably heard of blockchain before. You may even associate it with cryptocurrency.
But blockchain is much bigger than cryptocurrency. It's a transformative technology that has the power to change almost every industry.
And it's why we've uncovered one of the best blockchain stocks to buy in September 2018...
by Stephen Mack
Our new list of best stocks to buy now features a slew of tech companies, from young disrupters to old heavyweights.
Plus we have one promising play on a new trend in legal cannabis.
Don't miss these opportunities.
The Dow Jones Industrial Average jumped 39-points in premarket hours ahead of a busy day of economic announcements and statements by central banking leaders.
Finding the top pot stocks to watch can be difficult.
That's why we wanted to help.
Here are two of the top pot stocks to watch...
by Lee Adler
The Daily Treasury Statement data for the end of August showed some improvement in total tax collections, including a slight uptick in withholding taxes and an even bigger increase in excise taxes.
The numbers suggest that an early summer slowdown has ended. After the expected downward revisions in June and July jobs data, the August uptick in jobs was not a fluke. And the excise tax data suggests strong retail sales.
So, not an altogether bad summer – if you happen to be a politician or government taxman. But what about for investors?
Well surprise, surprise, surprise! Good news is bad news, which is what we've been talking about here all along.
Good economic news, as presaged by the uptick in tax receipts, will encourage the Fed to keep tightening.
And tighten it shall, in two ways: Most importantly (and most destructively), it will drain more money from the banking system. Secondarily, it will continue to rubber-stamp tightening money markets by raising the federal-funds rate.
And that, as I have been shaking my fist at the sky about for months, is really bearish.
The stuff has not hit the fan yet, but it is coming...
by
Investors shouldn't be concerning themselves with the new iPhone debut.
In this video, Capital Wave Strategist Shah Gilani lays out the true value of Apple stock...
Biotech firms offer extraordinary growth potential thanks to their development of new drugs.
If a drug wins FDA approval, the company's stock has the chance to rocket higher.
That's why we're bringing you the best biotech stocks to buy in September 2018...
